CD57 antibody
Quick Overview for CD57 antibody (ABIN6296495)
Target
See all CD57 (B3GAT1) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Purpose
- Mouse anti-Human CD57 Antibody [Sodium Azide Free]
-
Specificity
- Cell surface, cytoplasmic
-
Purification
- Human peripheral blood mononuclear cells were used as the immunogen for the anti-CD57 antibody.
-
Immunogen
- Human peripheral blood mononuclear cells were used as the immunogen for the anti-CD57 antibody.
-
-
-
-
Application Notes
-
Immunofluorescence: 0.5-1 μg/mL
Immunohistochemistry (FFPE): 2-4 μg/mL for 30 min at RT (1)
Prediluted format: incubate for 30 min at RT (2) -
Restrictions
- For Research Use only
-
-
-
Buffer
- In 1X PBS, BSA free, sodium azide free
-
Preservative
- Azide free
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- 2-8°C. The azide-free format should be aliquoted and stored at -20°C or colder.
-
-
- CD57 (B3GAT1) (beta-1,3-Glucuronyltransferase 1 (Glucuronosyltransferase P) (B3GAT1))
-
Alternative Name
- Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1
-
Background
-
Target Description: Anti-CD57 marks a subset of lymphocytes known as natural killer (NK) cells. Follicular center cell lymphomas often contain many NK cells within the neoplastic follicles. Anti-CD57 also stains neuroendocrine cells and their derived tumors, including carcinoid tumor and medulloblastoma. Anti-CD57 can also be useful in separating type B3 thymoma from thymic carcinoma when combined with a panel that includes antibodies against GLUT1, CD5, and CEA.
Gene Symbol: B3GAT1///GLCATP
-
Gene ID
- 27087
-
UniProt
- Q9P2W7
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-